139 related articles for article (PubMed ID: 21470651)
21. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration.
Condack C; Grivel JC; Devaux P; Margolis L; Cattaneo R
J Infect Dis; 2007 Aug; 196(4):541-9. PubMed ID: 17624839
[TBL] [Abstract][Full Text] [Related]
22. Measles virus targets DC-SIGN to enhance dendritic cell infection.
de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
[TBL] [Abstract][Full Text] [Related]
23. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.
Erlenhoefer C; Wurzer WJ; Löffler S; Schneider-Schaulies S; ter Meulen V; Schneider-Schaulies J
J Virol; 2001 May; 75(10):4499-505. PubMed ID: 11312320
[TBL] [Abstract][Full Text] [Related]
24. Measles virus receptors: SLAM and CD46.
Dhiman N; Jacobson RM; Poland GA
Rev Med Virol; 2004; 14(4):217-29. PubMed ID: 15248250
[TBL] [Abstract][Full Text] [Related]
25. Targeted cell entry of lentiviral vectors.
Funke S; Maisner A; Mühlebach MD; Koehl U; Grez M; Cattaneo R; Cichutek K; Buchholz CJ
Mol Ther; 2008 Aug; 16(8):1427-36. PubMed ID: 18578012
[TBL] [Abstract][Full Text] [Related]
26. The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.
Mateo M; Navaratnarajah CK; Syed S; Cattaneo R
J Virol; 2013 Aug; 87(16):9208-16. PubMed ID: 23760251
[TBL] [Abstract][Full Text] [Related]
27. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
[TBL] [Abstract][Full Text] [Related]
28. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.
Schoenhals M; Frecha C; Bruyer A; Caraux A; Veyrune JL; Jourdan M; Moreaux J; Cosset FL; Verhoeyen E; Klein B
Leukemia; 2012 Jul; 26(7):1663-70. PubMed ID: 22318450
[TBL] [Abstract][Full Text] [Related]
29. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.
Frecha C; Costa C; Lévy C; Nègre D; Russell SJ; Maisner A; Salles G; Peng KW; Cosset FL; Verhoeyen E
Blood; 2009 Oct; 114(15):3173-80. PubMed ID: 19667401
[TBL] [Abstract][Full Text] [Related]
30. Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head.
Massé N; Ainouze M; Néel B; Wild TF; Buckland R; Langedijk JP
J Virol; 2004 Sep; 78(17):9051-63. PubMed ID: 15308701
[TBL] [Abstract][Full Text] [Related]
31. Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain.
Seki F; Takeda M; Minagawa H; Yanagi Y
J Gen Virol; 2006 Jun; 87(Pt 6):1643-1648. PubMed ID: 16690929
[TBL] [Abstract][Full Text] [Related]
32. The measles virus hemagglutinin downregulates the cellular receptor SLAM (CD150).
Tanaka K; Minagawa H; Xie MF; Yanagi Y
Arch Virol; 2002; 147(1):195-203. PubMed ID: 11855632
[TBL] [Abstract][Full Text] [Related]
33. Identification of a second major site for CD46 binding in the hemagglutinin protein from a laboratory strain of measles virus (MV): potential consequences for wild-type MV infection.
Massé N; Barrett T; Muller CP; Wild TF; Buckland R
J Virol; 2002 Dec; 76(24):13034-8. PubMed ID: 12438629
[TBL] [Abstract][Full Text] [Related]
34. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
35. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus.
Hsu EC; Iorio C; Sarangi F; Khine AA; Richardson CD
Virology; 2001 Jan; 279(1):9-21. PubMed ID: 11145884
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
[TBL] [Abstract][Full Text] [Related]
37. Adaptation of wild-type measles virus to tissue culture.
Kouomou DW; Wild TF
J Virol; 2002 Feb; 76(3):1505-9. PubMed ID: 11773423
[TBL] [Abstract][Full Text] [Related]
38. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.
Dhiman N; Poland GA; Cunningham JM; Jacobson RM; Ovsyannikova IG; Vierkant RA; Wu Y; Pankratz VS
J Allergy Clin Immunol; 2007 Sep; 120(3):666-72. PubMed ID: 17560639
[TBL] [Abstract][Full Text] [Related]
39. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
[TBL] [Abstract][Full Text] [Related]
40. [The cellular receptor for measles virus: SLAM (CDw 150)].
Tatsuo H; Ono N; Tanaka K; Yanagi Y
Uirusu; 2000 Dec; 50(2):289-96. PubMed ID: 11276818
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
